Avricore Health (AVCRF) Non Operating Investment Income (2023 - 2024)
Avricore Health (AVCRF) posted quarterly Non Operating Investment Income of -$131688.6 for Q3 2024, up 38.07% year-over-year from -$95379.1 in Q4 2023, and up 38.07% quarter-over-quarter from -$212636.4 in Q3 2023.
Avricore Health (AVCRF) Non Operating Investment Income (2023 - 2024) Analysis & Trends
Avricore Health (AVCRF) has reported Non Operating Investment Income for 2 consecutive years, with -$131688.6 the latest figure, recorded in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -131,264.21 |
| Sep 30, 2024 | -131,264.21 |
| Sep 30, 2023 | -212,636.43 |
| Sep 30, 2023 | -212,636.43 |